Resumen

LAZO ROBLEJO, Yaily  y  LORES DELGADO, Danneris. Incretins: a new therapeutic alternative for the glycometabolic control of the type 2 diabetes mellitus. MEDISAN [online]. 2012, vol.16, n.3, pp. 445-451. ISSN 1029-3019.

There are now newer treatments to control temporarily the blood glucose levels of most patients with type 2 diabetes mellitus. Among these therapeutic agents are those that replicate or potentiate the effect of incretins as agonists of glucagon-related peptide-1 and dipeptidyl peptidase-4 inhibitors, which have advantages such as eliminating manifestations of hypoglycemia and neutral effect or decreased body weight. Nevertheless, conclusive clinical data that demonstrate their effectiveness will be provided over time.

Palabras clave : type 2 diabetes mellitus; incretins; glycometabolic control; glucagon-related peptide1; dipeptidyl peptidase-4.

        · resumen en Español     · texto en Español     · Español ( pdf )